Description

Propionyl-L-carnitine is a carnitine derivative and has a high affinity for muscular carnitine transferase. Propionyl-L-carnitine increases cellular carnitine content, thereby allowing free fatty acid transport into the mitochondria. Propionyl-L-carnitine alleviates the symptoms of PAD through a metabolic pathway, thereby improving exercise performance[1].–20°C, 3 years; 4°C, 2 years (Powder)–COVID-19-immunoregulation–C10H19NO4—-[1]Victor Kamoen, et al. Propionyl-L-carnitine for intermittent claudication. Cochrane Database Syst Rev. 2021 Dec 26;12(12):CD010117.–20064-19-1–217.26–95.0–CCC(O[C@@H](C[N+](C)(C)C)CC([O-])=O)=O–Inflammation/Immunology–H2O : ≥ 250 mg/mL–Endogenous Metabolite—-Metabolic Enzyme/Protease–Peptides